Related Experiment Video
Updated: Mar 13, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Codeine use among children in the United States: a nationally representative study from 1996 to 2013
Margaret J Livingstone1, Cornelius B Groenewald1, Jennifer A Rabbitts1
1Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Insights
Despite safety concerns, over a million children in the US used codeine in 2013. Safer alternatives are available, and healthcare providers should follow guidelines advising against pediatric codeine use.
Area of Science:
- Pediatric pharmacology
- Public health surveillance
- Pain management
Background:
- Codeine use in children raises safety concerns due to risks of respiratory depression and death.
- International health agencies recommend restricting codeine use in pediatric populations.
- The epidemiology of codeine utilization among children in the US was previously unknown.
Purpose of the Study:
- To investigate the patterns of codeine use in children aged 0-17 years within the United States.
- To analyze trends in pediatric codeine prescriptions from 1996 to 2013.
Main Methods:
- Cross-sectional analysis of data from the Medical Expenditure Panel Survey (MEPS) from 1996 to 2013.
- Examination of prevalence rates of codeine use in children over the study period.
- Multivariable logistic regression to identify factors associated with codeine use, including patient demographics.
Main Results:
- Codeine use among children remained relatively stable, with over 1 million children using it in 2013.
- Increased odds of codeine use were observed in adolescents (12-17 years), non-Northeastern regions, and children with poor physical health.
- Lower odds of codeine use were found in non-white children and those without insurance. Emergency physicians and dentists were primary prescribers, often for trauma-related pain.
Conclusions:
- Although pediatric codeine use has seen a decline, it remains prevalent, with over a million children using it in 2013.
- Healthcare providers need to be informed about guidelines recommending against codeine in children due to potential hazards.
- Safer analgesic alternatives for treating pain in children are available and should be considered.
Background:
Concerns regarding the safety of codeine have been raised. Cases of life-threatening respiratory depression and death in children have been attributed to codeine's polymorphic metabolic pathway. International health agencies recommend restricted use of codeine in children. Despite these recommendations, the epidemiology of codeine use among children remains unknown.
Aims:
Our objective was to examine patterns of codeine use in the US among children.
Methods:
A cross-sectional analysis of children of age 0-17 years from 1996 to 2013 in the US was performed. Data were extracted from MEPS, a nationally representative set of health care surveys. Prevalence rates of codeine use between 1996 and 2013 were examined. Multivariable logistic regression examined relationships between codeine use and patient demographics.
Results:
Codeine use remained largely unchanged from 1996 to 2013 (1.08 vs 1.03 million children, respectively). Odds of codeine use was higher in ages 12-17 (OR, 1.40; [1.21-1.61]), outside of the Northeastern US, and among those with poor physical health status (OR, 3.29 [1.79-6.03]). Codeine use was lower in children whose ethnicity was not white and those uninsured (OR, 0.47 [0.34-0.63]). Codeine was most frequently prescribed by emergency physicians (18%) and dentists (14%). The most common condition associated with codeine use was trauma-related pain.
Conclusions:
Pediatric codeine use has declined since 1996; however, more than 1 million children still used codeine in 2013. Health care providers must be made aware of guidelines advising against the use of codeine in children. Codeine is potentially hazardous and safer alternatives to treat children's pain are available.
More Related Videos
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Infants and Children
Drug Regulation
Drug Classes and Categories
Opioid Analgesics: Morphine and Other Natural Cogeners
Pharmacokinetics in Pediatric Patients: Drug Excretion